发明名称 Dimeric compounds such as N-(2-{7-[2-({3-[2-(acetylaminoethyl]-1-benzofuran-5-yl}oxy)ethoxy]-1-naphthyl}-ethyl)acetamide for the treatment of melatonin related disorders
摘要 Substituted dimeric compounds of Formula (I), to a process for their preparation and to the pharmaceutical compositions containing them, for treating pathologies associated with the melatoninergic system. Wherein, A represents a grouping of Formula (II); wherein Q represents a sulphur or oxygen atom; R1, R2 and R3, which may be identical or different, represent a hydrogen atom or a group Ra (wherein Ra represents an unsubstituted or substituted linear or branched C1-6alkyl group, an unsubstituted or substituted linear or branched C2-6alkenyl group, an unsubstituted or substituted linear or branched C2-6alkynyl group, an unsubstituted or substituted C3-8cycloalkyl group, an unsubstituted or substituted cycloalkyl-C3-8alkyl group in which the alkyl moiety is linear or branched, a polyhalo-C1-6alkyl group in which the alkyl moiety is linear or branched, an aryl group, an arylC1-6alkyl group in which the alkyl moiety is linear or branched, an arylC2-6alkenyl group in which the alkenyl moiety is linear or branched, a heteroaryl group, a heteroaryl-C1-6alkyl group in which the alkyl moiety is linear or branched or a heteroaryl-C2-6alkenyl group in which the alkenyl moiety is linear or branched), or the groups R2 and R3 can also form with the nitrogen atom carrying them a group selected from piperazinyl, piperidinyl and pyrrolidinyl; B represents a grouping of Formula (III); G1 and G3 which may be identical or different, represent a linear or branched alkylene chain containing from 1 to 4 carbon atoms that is optionally substituted by one or more identical or different groups selected from hydroxy, carboxy, formyl, Ra, ORa, COORa and CORa; Cy and Cy', which are different, represent a ring structure of the Formula (IV); wherein X and Y which may be identical or different, represent a sulphur, oxygen or carbon atom, or a CH or CH2 group, R4 represents a hydrogen or halogen atom, or a CF3, hydroxy, carboxy, formyl, amino, NHRa, NRaR1a, NHCORa, CONHRa, Ra, ORa, CORa or COORa group, wherein G2 substitutes the benzene ring, and G1 substitutes the ring containing X and Y in the case of Cy, and G2 substitutes the benzene ring and G3 substitutes the ring containing X and Y in the case of Cy', or a ring structure of Formula (V), wherein Z represents a sulphur or oxygen atom, or a CH2, NH, NSO2Ph or NRa group, D represents a benzene or pyridine ring, wherein G2 substitutes the D ring, and G1 substitutes the ring containing Z in the case of Cy, and G2 substitutes the D ring and G3 substitutes the ring containing Z in the case of Cy', G2 represents a chain of formula (VI), wherein W1, W2 and W3, which may be identical or different, represent a bond, an oxygen or sulphur atom, or a CH2, CHRa, NH or NRa group. n represents an integer 0=n=6, m represents an integer 0=m=6.
申请公布号 NZ504613(A) 申请公布日期 2001.06.29
申请号 NZ20000504613 申请日期 2000.05.18
申请人 ADIR ET COMPAGNIE 发明人 BENNEJEAN, CAROLINE;DELAGRANGE, PHILIPPE;RENARD, PIERRE;DESCAMPS-FRANCOIS, CAROLE;DEPREUX, PATRICK;YOUS, SAID;CHEVE, GWENAEL;GUILLAUMET, GERALD;VIAUD, MARIE-CLAUDE;LARRAYA, CARLOS
分类号 C07D319/20;A61K31/24;A61K31/343;A61K31/352;A61K31/357;A61K31/381;A61K31/403;A61K31/404;A61K31/4355;A61P1/14;A61P3/00;A61P9/00;A61P9/02;A61P25/00;A61P25/20;A61P25/24;A61P25/28;A61P43/00;C07C233/22;C07D209/16;C07D307/79;C07D307/80;C07D307/81;C07D311/58;C07D333/58;C07D333/60;C07D333/66;C07D339/08;C07D405/04;C07D405/06;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D471/04;(IPC1-7):A61K31/40;C07D401/12;C07D209/44;A61K31/435 主分类号 C07D319/20
代理机构 代理人
主权项
地址